Status: Recruiting
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
This is a prospective, multicenter, observational real-world study to explore the therapy patterns and clinical outcomes of Avapritinib in patients with metastatic or unresectable gastrointestinal stromal tumors.
Participants needed: 74
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Xinhua Zhang, MDUpdated: Feb 26, 2025Locations: 1
Eligibility criteria
Patients who are aged ≥ 18 years. [+6]
KIT or PDGFRA wild type. [+2]